Aim Bulletin
Hutchison Chi-Med gets FDA fast track approval for fruquintinib
Hutchison China MediTech, trading as ‘Chi-Med’, announced on Thursday that the US Food and Drug Administration (FDA) has granted ‘fast track designation’ for the development of ‘fruquintinib’.
Duke Royalty puts another £2.3m into Welltel Ireland
Alternative capital provider Duke Royalty announced a follow-on investment of £2. 3m into its existing royalty partner, the Dublin-headquartered telecoms, IT and network specialist Welltel Ireland, on Thursday.
Asos back in fashion as Credit Suisse ups price target
Credit Suisse has upped its target price for Asos on expectations for an improved sales performance in the second half.
Reabold upbeat on work programme at Parta area
Upstream oil and gas investment company Reabold Resources updated the market ahead of the start of well test operations at the Iecea Mica-1 (IMIC-1) well in Romania on Thursday, as part of the 2020 work programme.
Novacyt launches new Covid-19 test, extraction kits
Clinical diagnostics firm Novacyt launched three new products aimed at supporting laboratories testing for Covid-19 on Thursday.
Michelmersh 'swiftly' returns to full operational capacity
Brick manufacturer Michelmersh said on Thursday that it has "swiftly" returned to full operational capacity since recommencing production at all of its plants on 21 April.
Jubilee Metals secures rights to copper tailings in Zambia
Jubilee Metals Group has secured the rights to around 150 million tonnes of copper-containing surface tailings, targeted to be upgraded at site and refined at its Sable Refinery in Zambia, it announced on Thursday.
Tremor International 'severely impacted' by Covid-19
Advertising company Tremor International said on Thursday trading had been "severely impacted" by the Covid-19 outbreak, with clients cutting advertising budgets across all platforms.
Access Intelligence performs well in H1, issues no forward guidance
Software-as-a-Service solutions provider Access Intelligence said on Thursday that its underlying business had "performed well" through the volatility seen in the first half of 2020 but opted not to issue any forward guidance as a result of the ongoing Covid-19 pandemic.
Synairgen expands Covid-19 trial nationwide
Synairgen is to expand trials of a potential treatment for Covid-19 nationally, the respiratory drug specialist said on Thursday.
Empire progressing with Munni Munni acquisition as drilling begins
Exploration and development company Empire Metals updated the market on the proposed acquisition of a 58. 6% interest in Munni Munni - a subsidiary of ASX-listed Artemis Resources, and the beneficial owner of a 70% interest in the Munni Munni Palladium Project in Western Australia's West Pilbara - on Thursday.
Corero secures five new orders worth $1.5m
Corero Network Security announced five new headline customer wins for its ‘SmartWall’ distributed denial-of-service (DDoS) protection products in the last two months on Thursday, including two new contract wins through its partner Juniper, totaling more than $1. 5m (£1. 2m) over the course of the contracts.
Avacta reports promising findings on potential Covid therapy
Avacta Group announced on Thursday that collaborative work with the Centre for Virus Research at the University of Glasgow has shown that its ‘Affimer’ reagents, which bind to the SARS-COV-2 (Covid-19) virus spike protein, prevent infection of human cells by a SARS-COV-2 model virus, and therefore provide a potential therapy for Covid-19 infection.
Cora Gold signs term sheet to fund Sanankoro project
West Africa-focussed Cora Gold has signed a $21m (£16. 82m) mandate and term sheet with investment firm Lionhead Capital Advisors, to fund the future development of its flagship Sanankoro Gold Project in southern Mali, it announced on Thursday.